Defining Issues | February 2020
The SEC has issued guidance that provides disclosure considerations and reminds registrants to maintain effective disclosure controls and procedures when disclosing metrics in MD&A.
SEC Release No. 33-10751; 34-88094; IC-33795; FR-87
The SEC has issued guidance highlighting disclosure considerations when discussing key performance indicators and other metrics in MD&A.
The SEC generally expects disclosures to include:
Companies should also consider whether disclosure of the estimates or assumptions related to the metric or its calculation is necessary for the metric not to be materially misleading. If the method of calculating or presenting the metric changes, the company should consider the need to disclose:
The guidance also reminds registrants of the requirement to maintain effective disclosure controls and procedures when disclosing material KPIs or metrics in MD&A.
Non-GAAP financial measures
In-depth guidance on the SEC rules related to non-GAAP financial measures, with examples and illustrative SEC comments.
Financial reporting impacts of COVID-19
Guidance, updates and news covering financial reporting impacts of COVID-19
SEC matters
Keeping you up to date about SEC staff positions on reporting matters and proposed rulemaking that will affect registrants
Receive the latest financial reporting and accounting updates with our newsletters and more delivered to your inbox.
Access our accounting research website for additional resources for your financial reporting needs.